Cargando…

Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review

There is a strong demand for the identification of new biomarkers in colorectal cancer (CRC) diagnosis. Among all liquid biopsy analysts, cell-free circulating DNA (cfDNA) is probably the most promising tool with respect to the identification of minimal residual diseases, assessment of treatment res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vymetalkova, Veronika, Cervena, Klara, Bartu, Linda, Vodicka, Pavel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274807/ https://www.ncbi.nlm.nih.gov/pubmed/30373199 http://dx.doi.org/10.3390/ijms19113356

Ejemplares similares

Methylation-Based Therapies for Colorectal Cancer
por: Cervena, Klara, et al.
Publicado: (2020)

Colorectal Adenomas—Genetics and Searching for New Molecular Screening Biomarkers
por: Siskova, Anna, et al.
Publicado: (2020)

Distant Metastasis in Colorectal Cancer Patients—Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review
por: Filip, Stanislav, et al.
Publicado: (2020)

Discovery of Long Non-Coding RNA MALAT1 Amplification in Precancerous Colorectal Lesions
por: Siskova, Anna, et al.
Publicado: (2022)

MALAT1 in Liquid Biopsy: The Diagnostic and Prognostic Promise for Colorectal Cancer and Adenomas?
por: Cervena, Klara, et al.
Publicado: (2023)

Correction: Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival
por: Lu, Shun, et al.
Publicado: (2019)

The dynamics of telomere length in primary and metastatic colorectal cancer lesions
por: Kroupa, Michal, et al.
Publicado: (2023)

Analysis of MicroRNA Expression Changes During the Course of Therapy In Rectal Cancer Patients
por: Cervena, Klara, et al.
Publicado: (2021)

DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers
por: Caja, Fabian, et al.
Publicado: (2020)

Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases in Colorectal Cancer Patients
por: Vodicka, Pavel, et al.
Publicado: (2020)

MUC13-miRNA-4647 axis in colorectal cancer: Prospects to identifications of risk factors and clinical outcomes
por: Sojka, Ladislav, et al.
Publicado: (2022)

Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases MUTYH and hOGG1 in Colorectal Cancer Patients
por: Kavec, Miriam J., et al.
Publicado: (2022)

Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival
por: Lu, Shun, et al.
Publicado: (2019)

A novel c. 204 Ile68Met germline variant in exon 2 of the mutL homolog 1 gene in a colorectal cancer patient
por: VODICKA, PAVEL, et al.
Publicado: (2015)

Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients
por: Kunzmann, Andrew T., et al.
Publicado: (2019)

Functional Polymorphisms in DNA Repair Genes Are Associated with Sporadic Colorectal Cancer Susceptibility and Clinical Outcome
por: Jiraskova, Katerina, et al.
Publicado: (2018)

Relationship of telomere length in colorectal cancer patients with cancer phenotype and patient prognosis
por: Kroupa, Michal, et al.
Publicado: (2019)

Single Nucleotide Polymorphisms within Interferon Signaling Pathway Genes Are Associated with Colorectal Cancer Susceptibility and Survival
por: Lu, Shun, et al.
Publicado: (2014)

Molecular characteristics of mismatch repair genes in sporadic colorectal tumors in Czech patients
por: Vymetalkova, Veronika Polakova, et al.
Publicado: (2014)

Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis
por: Wang, Xin, et al.
Publicado: (2018)

Role of circulating free DNA in colorectal cancer
por: Matikas, Alexios, et al.
Publicado: (2016)

Monitoring of telomere dynamics in peripheral blood leukocytes in relation to colorectal cancer patients’ outcomes
por: Tomasova, Kristyna, et al.
Publicado: (2022)

Editorial: Strategies in overcoming the chemoresistance in colorectal cancer
por: Vodenkova, Sona, et al.
Publicado: (2023)

The Associations of Selenoprotein Genetic Variants with the Risks of Colorectal Adenoma and Colorectal Cancer: Case–Control Studies in Irish and Czech Populations
por: Mukhtar, Maryam, et al.
Publicado: (2022)

Clinical utility of circulating cell-free DNA in advanced colorectal cancer
por: Pereira, Allan A. Lima, et al.
Publicado: (2017)

Different primers for diagnosing circulating cell-free DNA of colorectal cancer
por: Shi, Hao, et al.
Publicado: (2020)

Double-strand break repair and colorectal cancer: gene variants within 3′ UTRs and microRNAs binding as modulators of cancer risk and clinical outcome
por: Naccarati, Alessio, et al.
Publicado: (2015)

Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer
por: Philipp, Alexander B, et al.
Publicado: (2014)

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature
por: Galanopoulos, Michail, et al.
Publicado: (2017)

Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review
por: Schraa, Suzanna J., et al.
Publicado: (2022)

Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer
por: Catalano, Calogerina, et al.
Publicado: (2018)

Detection of mutations in circulating cell‐free DNA in relation to disease stage in colorectal cancer
por: Liebs, Sandra, et al.
Publicado: (2019)

The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis
por: Basnet, Shiva, et al.
Publicado: (2016)

Analysis of colorectal cancer‐related mutations by liquid biopsy: Utility of circulating cell‐free DNA and circulating tumor cells
por: Takeda, Kohki, et al.
Publicado: (2019)

Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes
por: Vymetalkova, Veronika, et al.
Publicado: (2015)

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015)

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
por: Hao, T B, et al.
Publicado: (2014)

Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection
por: Fang, Qingxiao, et al.
Publicado: (2023)

Cell-free circulating tumor DNA in cancer
por: Qin, Zhen, et al.
Publicado: (2016)

Molecular Alterations in Circulating Cell-Free DNA in Patients with Colorectal Adenoma or Carcinoma
por: Hu, Ying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4rjnr162q9fm4645be231g1njs